Compare OVID & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | WEYS |
|---|---|---|
| Founded | 2014 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.9M | 486.0M |
| IPO Year | 2017 | 1995 |
| Metric | OVID | WEYS |
|---|---|---|
| Price | $2.56 | $59.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $6.40 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 37.5K |
| Earning Date | 11-10-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 1.84% |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ 3.23 |
| Revenue | $7,252,000.00 | ★ $276,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.90 |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $1.18 | $27.25 |
| 52 Week High | $3.11 | $68.39 |
| Indicator | OVID | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 64.68 |
| Support Level | $2.12 | $31.55 |
| Resistance Level | $2.67 | $68.39 |
| Average True Range (ATR) | 0.24 | 2.95 |
| MACD | 0.03 | 0.47 |
| Stochastic Oscillator | 44.95 | 53.17 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.